Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial
Fees or honoraria, 8 Oct 2026
Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial
Fees or honoraria, 1 Oct 2026
Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study
Grants or research support, 16 Sept 2026
The Alpha-1 Antitrypsin Z-allele associates with sarcopenia in the UK Biobank
Consulting or advice, Fees or honoraria, 14 Sept 2026
Normal age-related decline in forced vital capacity: a systematic review and meta-analysis
Fees or honoraria, 9 Sept 2026
Lipoprotein (a) variability in high cardiovascular risk individuals with hypertriglyceridemia and controlled LDL-C on statin therapy in REDUCE-IT
Grants or research support, 2 Sept 2026
Frailty Patterns, Reversibility, and Outcomes With a Magnetically Levitated Left Ventricular Assist Device
Fees or honoraria, 1 Sept 2026
Frailty assessment in people with hemophilia
Consulting or advice, Fees or honoraria, 31 Aug 2026
Effect on Lipoprotein(a) Oxidized Phospholipids of Lepodisiran, an Extended-Duration siRNA Targeting Lipoprotein(a)
Consulting or advice, 31 Aug 2026
Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA
Consulting or advice, Fees or honoraria, Grants or research support, 29 Aug 2026
Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study
Patents or royalties, Grants or research support, 28 Aug 2026
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study
Fees or honoraria, Grants or research support, 28 Aug 2026
Rates of Lipoprotein(a) Oxidation Accelerate at Elevated Levels and Attenuate With Atorvastatin Active Metabolites Compared With Other Statins
Grants or research support, 24 Aug 2026
The impact and evolution of environmental/occupational, behavioural, and metabolic risk factors on CVD burdens in the Asia-Pacific region from 1990 to 2023: a secondary analysis of the Global Burden of Disease Study 2023
Consulting or advice, Fees or honoraria, 23 Aug 2026
Burden of cardiovascular diseases in the Asia-Pacific region from 1990 to 2023, with forecasts to 2050: a secondary analysis of the Global Burden of disease study 2023
Consulting or advice, Fees or honoraria, 21 Aug 2026
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis
Grants or research support, 18 Aug 2026
Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial
Consulting or advice, Grants or research support, 18 Aug 2026
Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes
Grants or research support, 17 Aug 2026
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis
Grants or research support, 7 Aug 2026
Medial temporal ageing-related tau astrogliopathy below 66 years is associated with neurodegeneration
Consulting or advice, Board or leadership role, 3 Aug 2026